New Method of Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) for Rat Brain Research
Manganese (Mn2+)-enhanced MRI (MEMRI) is known to provide insight into functional and anatomical biology. However, this method, which uses Mn2+ as a MRI-detectable contrast agent, has drawbacks such as the toxicity to cells beyond a certain level of Mn2+. In this study, we attempt to determine a new...
Saved in:
Published in | Experimental Animals Vol. 61; no. 2; pp. 157 - 164 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
Japanese Association for Laboratory Animal Science
2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Manganese (Mn2+)-enhanced MRI (MEMRI) is known to provide insight into functional and anatomical biology. However, this method, which uses Mn2+ as a MRI-detectable contrast agent, has drawbacks such as the toxicity to cells beyond a certain level of Mn2+. In this study, we attempt to determine a new method of ICV administration, the optimal concentration of administered Mn2+ and the optimal MEMRI acquisition time following administration. Male Sprague-Dawley rats were used in the following experimental sessions: (1) intracerebroventricular (ICV) cannula implantation in the region of the cisterna magna, (2) serial dilution of MnCl2 (20–80 mM), (3) ICV administration of MnCl2 through the cannula, and (4) T1-weighted MRI measurements. We confirmed that cannula implantation in the region of the cisterna magna was a new ICV injection method for the administration of a contrast agent. The optimal concentration for MEMRI was 20/50 mM/μl of MnCl2. The MEMRI data acquired at different time points indicate that most signal enhancement is maintained during 14–48 h after contrast agent injection, and 24 h was the optimal time to acquire images of the rat brain. The present study offers optimized parameters for contrast agent injection that would be a good basis for studies using MEMRI to research the rat brain. |
---|---|
ISSN: | 1341-1357 1881-7122 |
DOI: | 10.1538/expanim.61.157 |